Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Nature Team ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   10.4% 8.9% 6.1% 5.6% 7.5% 9.8% 18.6% 18.6%   Credit score (0-100)   25 29 38 39 32 24 7 7   Credit rating   BB BB BBB BBB BB BB B B   Credit limit (kDKK)   -0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   261 615 1,393 1,041 872 1,065 0.0 0.0   EBITDA   105 119 448 -11.3 -8.3 92.2 0.0 0.0   EBIT   105 119 448 -11.3 -8.3 92.2 0.0 0.0   Pre-tax profit (PTP)   61.0 106.9 427.8 -74.8 -63.8 31.1 0.0 0.0   Net earnings   61.0 106.9 361.9 -63.9 -63.8 31.1 0.0 0.0   Pre-tax profit without non-rec. items   61.0 107 428 -74.8 -63.8 31.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -301 -194 168 104 40.0 71.1 21.1 21.1   Interest-bearing liabilities   276 401 208 631 442 421 0.0 0.0   Balance sheet total (assets)   452 995 1,935 1,633 1,263 1,556 21.1 21.1   Net Debt   276 401 78.7 631 442 421 -21.1 -21.1     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   261 615 1,393 1,041 872 1,065 0.0 0.0   Gross profit growth   54.6% 136.2% 126.4% -25.3% -16.2% 22.1% -100.0% 0.0%   Employees   1 2 3 2 2 2 0 0   Employee growth %   -50.0% 100.0% 50.0% -33.3% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   452 995 1,935 1,633 1,263 1,556 21 21   Balance sheet change%   30.2% 120.1% 94.4% -15.6% -22.7% 23.2% -98.6% 0.0%   Added value   105.1 118.5 447.6 -11.3 -8.3 92.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   40.3% 19.3% 32.1% -1.1% -0.9% 8.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.4% 20.0% 29.9% -0.3% 0.4% 7.2% 0.0% 0.0%   ROI %   38.3% 55.9% 115.0% -1.0% 1.0% 20.7% 0.0% 0.0%   ROE %   15.3% 14.8% 62.2% -47.1% -88.7% 56.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -40.0% -16.3% 8.7% 6.4% 3.2% 4.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   262.2% 338.2% 17.6% -5,572.5% -5,345.2% 456.2% 0.0% 0.0%   Gearing %   -91.6% -206.4% 124.2% 607.7% 1,104.1% 591.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   16.2% 25.8% 12.9% 16.5% 13.0% 16.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.3 0.7 0.3 0.3 0.3 0.0 0.0   Current Ratio   0.6 0.8 1.1 1.1 1.0 1.0 0.0 0.0   Cash and cash equivalent   0.1 0.1 129.7 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -301.1 -188.3 173.6 109.7 32.5 63.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   105 59 149 -6 -4 46 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   105 59 149 -6 -4 46 0 0   EBIT / employee   105 59 149 -6 -4 46 0 0   Net earnings / employee   61 53 121 -32 -32 16 0 0